FDA Delays Novavax Approval

News

FDA approves Moderna’s next-generation COVID-19 vaccine

Moderna Wins FDA Approval for Next-Gen COVID-19 Vaccine Despite ‘Investor Nervousness’

Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the FDA’s attitude toward mRNA and COVID-19 vaccines that have investors worried.

Rheumatology Advisor · 1d

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Reuters on MSN · 17d

FDA approves Novavax COVID vaccine with new conditions

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.The vaccine's prospects were thrown into doubt after the FDA missed its April 1 target to approve the shot,

STAT18d

Novavax wins narrowed approval for its Covid-19 shot after delay

The Food and Drug Administration has finally approved Novavax’s Covid ... an emergency use authorization. The FDA missed an April 1 deadline to rule on Novavax’s application.

4don MSN

FDA approves Moderna’s new lower-dose COVID-19 vaccine

By The Associated Press The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA approves Moderna’s next-generation COVID-19 vaccine

Trending now